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Copper (Cu) is an essential cofactor for a variety of
metabolic functions, and the regulation of systemic
Cu metabolism is critical to human health. Dietary
Cu is absorbed through the intestine, stored in the
liver, and mobilized into the circulation; however,
systemic Cu homeostasis is poorly understood.
We generated mice with a cardiac-specific knockout
of the Ctr1 Cu transporter (Ctr1hrt/hrt), resulting in
cardiac Cu deficiency and severe cardiomyopathy.
Unexpectedly, Ctr1hrt/hrt mice exhibited increased
serum Cu levels and a concomitant decrease in
hepatic Cu stores. Expression of the ATP7A Cu
exporter, thought to function predominantly in intes-
tinal Cu acquisition, was strongly increased in liver
and intestine ofCtr1hrt/hrtmice. These studies identify
ATP7A as a candidate for hepatic Cu mobilization
in response to peripheral tissue demand, and illumi-
nate a systemic regulation in which the Cu status
of the heart is signaled to organs that take up and
store Cu.
INTRODUCTION
Copper (Cu) is an essential element that has the ability to exist in
two oxidation states, Cu+ and Cu2+. This redox property of Cu
has been harnessed during the evolution of Cu-containing
enzymes, which use Cu as a cofactor during hydrolytic, electron
transfer and oxygen-utilization reactions to carry out a diverse
array of functions from mitochondrial oxidative phosphorylation
to peptide hormone maturation (Kim et al., 2008; Madsen and
Gitlin, 2007a). Consistent with the broad biochemical roles of
Cu-dependent enzymes, Cu deficiency in mammals has been
demonstrated to result in permanent impaired cognitive and
motor function, embryonic and neonatal abnormalities, and
anemia (Madsen and Gitlin, 2007b; Prohaska, 2000). Although
many of the proteins involved in Cu uptake and distribution at
the cellular level have been identified, the mechanisms for the
regulation of systemic Cu absorption in multicellular organisms
are not well understood (Kim et al., 2008).CCtr1 is a homotrimeric integral membrane protein, conserved
from yeast to humans, that transports Cu across the plasma
membrane with high affinity and specificity (Hamza et al.,
2003; Hua et al., 2009; Nose et al., 2006b). Intracellular Cu is
routed to cytosolic Cu, Zn superoxide dismutase by the CCS
Cu chaperone, to cytochrome oxidase through a series of mito-
chondrial-associated Cu-binding proteins and to the secretory
compartment by the Atox1 chaperone (Cobine et al., 2006;
Culotta et al., 2006; Lutsenko et al., 2007). Atox1 delivers Cu to
either of the structurally related ATP7A or ATP7B Cu-transport-
ing ATPases (Hamza et al., 2003; Linz and Lutsenko, 2007),
through which Cu is pumped into the lumen of the secretory
machinery for loading onto Cu-dependent proteins such as
ferroxidases, lysyl oxidase, and peptide hormone-amidating
enzymes (El Meskini et al., 2003; Hellman et al., 2002; Petris
et al., 2000). In intestinal epithelial cells (IECs), Cu is transported
across the basolateral membrane by ATP7A, where it is trans-
ported via the portal circulation to the liver, the primary site of
Cu storage. Excess liver Cu is removed by biliary excretion via
the action of the ATP7B Cu pump, and it has been proposed
that an as-yet-unidentified Cu transporter may function in Cu
mobilization from the liver to peripheral tissues (De Domenico
et al., 2008; Lutsenko et al., 2008). While the coordinated actions
of organs are likely to be critical for normal peripheral Cu homeo-
stasis, and the hormonal regulation by hepcidin plays an impor-
tant role in systemic iron metabolism (De Domenico et al., 2008;
Roy et al., 2007), the regulatory mechanism by which hepatic
Cu stores aremobilized to the peripheral circulation under condi-
tions of Cu demand remains unclear.
Cardiac tissue exhibits a particularly high demand for Cu in
order to sustain mitochondrial oxidative phosphorylation to
generate large amounts of energy for muscle contraction,
peptide hormone biogenesis, oxidative stress protection, and
other critical functions (Medeiros et al., 1993). Animal models of
dietary or genetically imposedCudeficiency demonstrate severe
cardiovascular dysfunction resulting in aneurysm, cardiac hyper-
trophy, and other cardiovascular functional defects (Mandinov
et al., 2003; Prohaska and Heller, 1982). Cardiac hypertrophy is
an adaptive response to heart pressure overload due to preg-
nancy, exercise, and other stresses, which enables the heart to
increase its pumping activity via elevated contractility (Frey and
Olson, 2003; Schannwell et al., 2002a). If the stressful stimuli
persist, depending on the individual conditions such as geneticell Metabolism 11, 353–363, May 5, 2010 ª2010 Elsevier Inc. 353
Figure 1. Cardiac-Specific Knockdown of
the Drosophila Ctr1A Cu Ion Channel
(A) Knockdown of Ctr1A in the dorsal vessel.
Immunoblot of crudely dissected Drosophila
dorsal vessel from wild-type (WT) and TinCGal4/
UAS-Ctr1ARNAi flies (Ctr1RNAi). Total tissue protein
extracts were probed with anti-Ctr1A peptide anti-
body or anti-ERK as a loading control.
(B) Representative optical coherence tomography
(OCT) images for wild-type and TinCGal4/UAS-
Ctr1ARNAi flies.
(C) End systolic dimension (ESD) measurements
for wild-type and TinCGal4/UAS-Ctr1ARNAi flies.
Error bars, SD; *p = 0.00073 versus wild-type.
(D) Fractional shortening measurements for
wild-type and TinCGal4/UAS-Ctr1ARNAi flies. Error
bars, SD; *p < 0.001 versus wild-type.
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becomes irreversible and frequently leads to cardiac dysfunction
and heart failure (Carabello, 2002; Schannwell et al., 2002b).
While Cu deficiency has been known to disrupt cardiovascular
function and lead to cardiac hypertrophy, it has not been estab-
lished whether Cu deficiency-induced cardiac hypertrophy is
due to an overall peripheral Cu deficiency or an intrinsic
cardiac-specific requirement for Cu to maintain normal function
(Jiang et al., 2007; Kelly et al., 1974; Klevay, 2001; Pyatskowit
and Prohaska, 2007).
Here we report the generation of fruit fly and mouse models
of Cu deficiency-mediated cardiac hypertrophy via cardiac-
specific knockout of the Ctr1 Cu transporter. Our analysis of
the mouse model demonstrates that a cardiac-specific Ctr1
knockout is sufficient to trigger a severe cardiac hypertrophy.
While Cu accumulation in cardiac tissue from Ctr1hrt/hrt mice
was decreased, we observed an unexpected increase in serum
Cu levels and a concomitant decrease in hepatic Cu stores.
Moreover, we observed a striking increase in the expression of
the ATP7A Cu efflux pump in the liver and IECs of Ctr1hrt/hrt
mice, but not in other peripheral tissues or in wild-type mice.
These studies implicate ATP7A as a key component for hepatic
Cu mobilization shortly after birth and during times of peripheral
Cu deficiency. Moreover, these results uncover a systemic Cu
homeostasis regulatory mechanism that signals the Cu status
of the heart, and potentially other peripheral organs, to tissues
involved in Cu uptake and storage.
RESULTS
Dorsal Vessel Knockdown of Drosophila Ctr1A Leads
to Cardiomyopathy
A dietary or genetically imposed peripheral Cu deficiency due
to intestinal-specific ablation of Ctr1 results in severe dilated
cardiomyopathy and cardiac hypertrophy (Nose et al., 2006a;
Prohaska, 1983). To ascertain if Cu deficiency-induced cardio-
myopathy is due to a cardiac-specific requirement for Cu, rather
than a general Cu deficiency, as proof of principle we first gener-
ated a metazoan model with a cardiac-specific Ctr1 knockdown354 Cell Metabolism 11, 353–363, May 5, 2010 ª2010 Elsevier Inc.in fruit flies. Previous studies established that the fruit fly,
Drosophila melanogaster, is a facile experimental system for
the identification of genes associated with adult human cardio-
myopathy, as fly cardiovascular function can be evaluated by
optical coherence tomography (Wolf et al., 2006). Moreover, flies
heterozygous for the primary Cu transporter, Ctr1A, exhibit Cu
remedial defects in heart beat rate and in the maturation of
cardiostimulatory peptides (Turski and Thiele, 2007). As shown
in Figures 1A–1D, RNAi-mediated knockdown of Ctr1A specifi-
cally in the dorsal vessel, the functional equivalent of the fly
heart, resulted in increased end systolic dimensions along
with reduced fractional shortening as compared to control flies.
These studies suggest that metazoan cardiac-specific Cu defi-
ciency is sufficient to generate a severe cardiomyopathy and
prompted further investigation in a mammalian model system.
Generation of a Cardiac-Specific Ctr1 Knockout Mouse
Model
To evaluate the consequences of a specific reduction in cardiac
Cu load in mammals, mice were generated in which the gene
encoding the Ctr1 Cu transporter was excised by crossing
Ctr1flox/flox mice with mice specifically driving nuclear-localized
Cre recombinase in cardiac tissue via the a-myosin heavy-chain
(MHC) promoter (Agah et al., 1997). The cardiac-specific Ctr1-
depleted mice, hereafter referred to as Ctr1hrt/hrt, were born at
the expected Mendelian frequency and exhibited normal growth
for approximately 5 days as compared to wild-type littermates.
Within a week, Ctr1hrt/hrt mice began to exhibit dramatic growth
retardation, with the majority dying within 3 weeks after birth
(Figures 2A–2C). Immunoblotting of total protein extracts and
diagnostic PCR analysis of DNA from several tissues revealed
cardiac-specific and efficient knockout of Ctr1 (Figure 2D and
see Figures S1A–S1C available online). Accordingly, the steady-
state levels of the Cu chaperone for Cu, Zn superoxide dismu-
tase, CCS, and mitochondrial cytochrome oxidase subunit IV
(COX IV), previously shown to be elevated or reduced, respec-
tively, in response to Cu deficiency (Bertinato and L’Abbe,
2003; Caruano-Yzermans et al., 2006; Gybina and Prohaska,
2006; West and Prohaska, 2004) were altered as expected for
Figure 2. Generation of a Cardiac-Specific
Knockout of the Mouse Ctr1 Gene
(A) Growth of Ctr1hrt/hrt mice. The body mass in
grams (g) for Ctr1hrt/hrt mice (red) or control litter-
mates (blue) as a function of age after birth in
days is shown.
(B) Ctr1hrt/hrt and Ctr1flox/flox littermates at P10.
A ruler is included as a size reference (in centi-
meters).
(C) Kaplan-Meier plot showing postnatal survival
of control (blue, n = 69; Ctr1flox/flox, Ctr1flox/+, and
Ctrhrt/+) and Ctr1hrt/hrt mice (red, n = 25).
(D) SDS-PAGE analysis of total Triton X-100
solubilized heart extracts of two representative
Ctr1flox/flox and Ctr1hrt/hrt mice. Tissues were
probed for Ctr1, CCS (copper chaperone for Cu,
Zn superoxide dismutase), COX IV (mitochondrial
cytochrome oxidase subunit V), and tubulin as
a loading control. The arrows indicate the posi-
tions of monomeric (at approximately 17 kD) and
heterogeneous glycosylated form (at approxi-
mately 35 kD) of Ctr1, both of which are dramati-
cally reduced in the Ctr1hrt/hrt mice.
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analyzed, steady-state levels of CCS were increased only in
cardiac tissue from Ctr1hrt/hrt mice compared to control litter-
mates (Figure S1C).
Cardiac-Specific Ctr1 Ablation Is Sufficient to Trigger
a Severe Cardiac Hypertrophy
Despite Ctr1hrt/hrt mice being significantly smaller than age-
matched control littermates (Figures 2A and 2B), hearts from
Ctr1hrt/hrt mice were dramatically enlarged and the heart weight
to total body weight ratio was increased nearly 3-fold, suggest-
ing that cardiac-specific loss of Ctr1 leads to cardiac hyper-
trophy (Figures 3A and 3B). To further investigate this anatomical
phenotype, markers that are elevated with pathological cardiac
hypertrophy were evaluated by RNA blotting (Dorn et al.,
2003). As shown in Figure 3C, mRNA levels for atrial natriuretic
peptide (ANP), b-type natriuretic peptide (BNP), and skeletal
actin (SA) were dramatically elevated in both male and female
Ctr1hrt/hrt mice as compared to control Ctr1flox/flox littermates.
Immunohistochemical interrogation of fixed cardiac tissue from
Ctr1hrt/hrt mice showed cardiomyocyte enlargement (Figure 3D),
overt endocardial fibrosis (Figure 3E), and disordered sarcomere
arrays, with enlarged cardiomyocytes harboring swollen mito-
chondria and morphologically irregular cristae observed by
electron microscopy that are typical of a cardiac myopathic
process (Figure 3F).
Physiological Consequences of Cardiac Loss of Ctr1
in Neonatal and Adult Mice
To investigate the physiological consequences of cardiac-
specific Ctr1 knockout, heart function was evaluated by echo-
cardiography and electrocardiography. Ctr1hrt/hrt mice of post-
natal day 10 (P10) exhibited left ventricular dilation (both diastolicC[LVDd] and systolic [LVDs]), increased left ventricular mass
(LVm), decreased fractional shortening, and a marked decrease
in heart rate (Figures 4A–4C). Moreover, representative electro-
cardiogram recordings of P10 Ctr1hrt/hrt and Ctr1flox/flox litter-
mates showed evidence for striking bradycardia and possibly
heart block (Figure 4D). To further investigate the cardiac
contractility of Ctr1hrt/hrt mice, we quantified the expression
levels of a calcium pump, SERCA2, and its major regulator,
phospholamban (PLB) (MacLennan and Kranias, 2003), in the
heart of Ctr1hrt/hrt mice. While SERCA2 expression was margin-
ally decreased, both PLB and phospho-PLB (Ser-16) exhibited
dramatically elevated expression compared to control mice (Fig-
ure 4E), suggesting that cardiac calcium cycling is significantly
disrupted in the Ctr1hrt/hrt mice.
These results from the constitutive cardiac-specific Ctr1
knockout suggest that Cu accumulation mediated by the Ctr1
Cu transporter is critical for the prevention of dilated cardiomy-
opathy during early postnatal stages. However, because the
MHC-Cre transgene is expressed during embryonic develop-
ment (Subramaniam et al., 1991), this could be due to a develop-
mental requirement for cardiac Ctr1 in Cu uptake. To address
this possibility, a mouse line was generated with an inducible
Cre transgene (MHC-Cre-ER) (Sohal et al., 2001; Xiong et al.,
2007) in which cardiac-specific Cre recombinase was activated
for Ctr1 excision only after administration of 4-OH-tamoxifen
(OHT) to 2- or 7-month-old mice (Figure S2A). Consistent with
a Cu deficiency-induced cardiomyopathy, both cohorts showed
strong cardiac-specific reduction of Ctr1, an increase in the
steady-state levels of the CCS Cu chaperone (Figure 4F), and
decreased Cu levels (data not shown). These mice began to
die at 2 days after OHT administration (Figure S2B). Further-
more, these mice exhibited an enlarged heart (Figures S2C and
S2D), dilated left ventricle with decreased fractional shortening,ell Metabolism 11, 353–363, May 5, 2010 ª2010 Elsevier Inc. 355
Figure 3. Ctr1hrt/hrt Mice Exhibit Cardiac
Hypertrophy
(A) Gross morphology of P10 hearts from
Ctr1flox/flox and Ctr1hrt/hrt mice.
(B) Quantitation of heart weight/body weight ratio
from Ctr1flox/flox (blue, n = 7) and Ctr1hrt/hrt (red,
n = 7) mice. Error bars, SD; p < 0.0001 versus
Ctr1flox/flox.
(C) Markers of cardiac hypertrophy. Heart-specific
mRNA from male and female Ctr1flox/flox and
Ctr1hrt/hrtmicewas analyzed byRNAblotting using
32P-labeled DNA probes to atrial natriuretic
peptide (ANP), b-type natriuretic peptide (BNP),
and skeletal actin (SA). Ribosomal RNA (rRNA) is
shown as a loading control.
(D) Heart sections from P10 Ctr1flox/flox and
Ctr1hrt/hrt were stained with H&E. (Left panel)
Ctr1flox/flox; (right panel) Ctr1hrt/hrt (403 magnifica-
tion; scale bar, 50 mm).
(E) Representative cardiac sections stained
with Masson’s trichome demonstrates extensive
fibrosis (gray staining) in the ventricular endocar-
dium region of tissue from Ctr1hrt/hrt mice,
indicated with an arrowhead, as compared to
Ctr1flox/flox controls (403 magnification; scale
bar, 50 mm).
(F) Electron microscopy of cardiac tissue (18003
magnification of cardiac thin sections; upper
panels, 30003magnification of cardiac thin sections; lower panels, scale bar, 1mm). (Left panels) Ctr1flox/flox; (right panels) Ctr1hrt/hrt. Thin section electron micro-
graphs of cardiac tissues fromCtr1hrt/hrtmice show abnormally enlargedmitochondria with disrupted cristae structures. Myofilaments andmitochondria are indi-
cated with arrowheads.
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and cardiomyocyte enlargement (Figure 4G) within 5 days after
administration of OHT. Taken together, these results demon-
strate that the Ctr1 Cu transporter is critical for maintenance of
cardiac function and for the prevention of cardiomyopathy in
both neonatal and adult mammals. Moreover, coupled with the
results obtained from Ctr1A knockdown experiments in the fly
dorsal vessel, these results suggest a specific and evolutionarily
conserved role for the Ctr1 Cu transporter in cardiovascular
function.
A Systemic Copper Signaling Mechanism
Hearts from Ctr1hrt/hrt mice expressed significantly less Ctr1 in
cardiac tissue and accumulated less Cu as compared to wild-
type littermates (Figure 5A). Hearts from Ctr1hrt/hrt mice also
exhibited a strong diminution of mitochondrial cytochrome
oxidase activity as compared to tissue fromwild-type littermates
(Figure 5B), indicating that Ctr1 is the major Cu importer in the
heart. Surprisingly, while the Ctr1 gene is not excised and Ctr1
protein expression is not decreased in the liver of Ctr1hrt/hrt
mice (Figures S1B and S1C), Cu levels in the liver are decreased
by approximately 20%, and serum Cu is elevated by approxi-
mately 30% (Figure 5A). No elevations in serum Fe or Zn were
apparent in these same samples (Figures S3A and S3B). These
observations suggested that under conditions of cardiac Cu
deficiency, pools of Cu in the liver, the major storage organ,
are reduced, and there is a concomitant increase in Cu in
the peripheral circulation. While the ATP7B Cu-transporting
ATPase is known to efflux liver Cu into the bile for excretion,
the mechanisms by which liver Cu storage pools are mobilized
into the circulation are not known. We examined the expression356 Cell Metabolism 11, 353–363, May 5, 2010 ª2010 Elsevier Inc.levels of potential Cu-exporting proteins in the liver and observed
a dramatic elevation of the ATP7A Cu efflux pump in Ctr1hrt/hrt
mice as compared to control littermates (Figure 5C). This was
not anticipated, since ATP7A is not highly expressed in the liver
in Cu-adequate animals and a heptatic function for ATP7A had
not been previously identified. Semiquantative RT-PCR revealed
that ATP7A mRNA levels are strongly elevated in liver tissues
from Ctr1hrt/hrt mice compared to control littermates (Figure 5D),
whereas ATP7B steady-state mRNA levels remained unchanged
and ATP7B protein levels are rather marginally decreased
(Figure 5F). Evaluation of ATP7A localization in the liver from
Ctr1hrt/hrt mice revealed that while ATP7A is poorly expressed
in wild-type liver, in Ctr1hrt/hrt mice the ATP7A signal is
strong and is enriched toward the sinusoidal space (Figure 5E).
Moreover, liver and serum ceruloplasmin protein levels are
unchanged inCtr1hrt/hrtmicecompared to controlmice (Figure 5F
and Figure S3C). These results suggest that changes in liver and
serumCu levels in theCtr1hrt/hrtmice are not due to differences in
the synthesis or secretion of ATP7B or ceruloplasmin.
It is well established that the intestinal enterocyte is a key regu-
latory point for Cu absorption into the body (Llanos and Mercer,
2002; Nose et al., 2006a; Turnlund, 1998). However, little is
known about how the small intestine responds to changes in
the Cu status or Cu demands of peripheral tissues. Since
expression of the ATP7A Cu-transporting ATPase is strongly
elevated in the liver of Ctr1hrt/hrt mice, we evaluated ATP7A in
IECs in this background. As shown in Figure 5G, ATP7A expres-
sion is dramatically elevated in the IECs from Ctr1hrt/hrt mice as
compared to control Ctr1flox/flox littermates. Moreover, these
IECs show a slight elevation of CCS, suggesting that these cells
are somewhat Cu deficient. Levels of the intestinal glucose
Figure 4. Cardiac Dysfunction Resulting
from Loss of the Ctr1 Cu Ion Channel
(A) Representative echocardiogram M-mode
images from Ctr1flox/flox and Ctr1hrt/hrt at postnatal
10 days.
(B) Quantitation of left ventricular diastolic dimen-
sion (LVDd), left ventricular systolic dimension
(LVDs), fractional shortening, and left ventricular
mass (LVm) for Ctr1flox/flox (n = 10) and Ctr1hrt/hrt
mice (n = 9). Error bars, SD; *p < 0.0001 versus
Ctr1flox/flox.
(C) Mouse heart rate measurements demonstrate
an 50% decrease in heart rate in Ctr1hrt/hrt mice
(n = 10) relative to control mice (n = 9). Error
bars, SD; *p < 0.0001 versus Ctr1flox/flox.
(D) Electrocardiographic analysis of Ctr1flox/flox
and Ctr1hrt/hrt mice from P10 reveal a bradycardia
due to cardiac-specific loss of Ctr1.
(E) SDS-PAGE analysis of total heart extracts of
two independent Ctr1flox/flox (flox) and two inde-
pendent Ctr1hrt/hrt mice (hrt). Immunoblots were
probed for SERCA-2, P-PLB (phospho-phospho-
lamban, Ser-16), PLB (phospholamban), and
tubulin as a loading control.
(F) Immunoblot of cardiac tissues for Ctr1, CCS,
and SOD1 (included as loading control) from two
representative 2-month-old Ctr1flox/flox mice and
twoCtr1flox/flox; MHC-Cre-ERmice after tamoxifen
(OHT) treatments. 1 and 2 indicate samples from
two independent mice of each genotype.
(G) Heart sections from 2- (upper panels) and 7-
month-old (lower panels) Ctr1flox/flox and Ctr1flox/flox;
MHC-Cre-ER mice injected with OHT were stained
with H&E. d(Left panel) Ctr1flox/flox; (right panel)
Ctr1flox/flox; MHC-Cre-ER (403 magnification, scale
bar, 50 mm).
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control mice (Figure S3D). Elevated hepatic ATP7A levels were
also observed from induced-cardiac Ctr1 deletion mice
compared to control mice (Figure S3E). Taken together these
results demonstrate that in response to cardiac-specific Cu defi-
ciency, ATP7A Cu transporter levels are dramatically elevated in
both the small intestine and liver, the primary sites of Cu absorp-
tion and storage, respectively.
Hepatic ATP7A Expression Correlates with Cu
Mobilization
What physiological conditions would demand elevated ATP7A
expression in the primary Cu uptake and Cu storage organs?
Previous studies demonstrated that Cu levels in the liver of post-
natal mice are high and that these levels gradually decrease as
mice age under standard weaning and diet conditions (AllenCell Metabolism 11, 353et al., 2006; Pyatskowit and Prohaska,
2008). We tested whether decreased Cu
status in the liver, as a function of time
after birth, is associated with changes in
the levels of ATP7A in mice reared on
a normal diet. As shown in Figure 6A,
expression levels of COX IV did not
change significantly in the livers of miceover the first 6months of life, suggesting that the liver maintained
a level of Cu sufficient to sustain cytochrome oxidase assembly.
The levels of liver ceruloplasmin, a Cu-dependent ferroxidase
involved in Fe loading onto transferrin, are also not significantly
altered in these mice. However, while liver ATP7A levels are
very high immediately after birth, they strongly decrease in
a time-dependent manner such that ATP7A levels are only
modestly detected 6 months after birth (Figure 6A). The hepatic
Cu content in thesemice demonstrated that decreased Cu levels
are associated with decreased expression of hepatic ATP7A
(Figure 6B). Notably, expression of ATP7A in the liver of P10
Ctr1hrt/hrt mice is strongly elevated beyond that of P10 wild-
type mice (Figure 6C), suggesting that the increased Cu demand
in cardiac tissue of Ctr1hrt/hrt mice further enhances ATP7A
expression. These data further suggest that ATP7Amay function
in hepatic Cu efflux early after birth, when Cu is being loaded into–363, May 5, 2010 ª2010 Elsevier Inc. 357
Figure 5. ATP7A Expression Is Increased in
the Liver and Intestine of Ctr1hrt/hrt Mice
(A) Tissue Cu levels inCtr1hrt/hrtmice are shown as
a percentage of Cu levels from Ctr1flox/flox mice
(100%). Error bars, SD; *p < 0.005 versus Cu levels
inCtr1flox/flox. H, heart; B, brain; M, muscle; L, liver;
S, serum.
(B) Mitochondrial cytochrome oxidase activity in
cardiac tissue from Ctr1flox/flox (blue, n = 4) and
Ctr1hrt/hrt (red, n = 5) mice. Error bars, SD; *p <
0.005 versus Ctr1flox/flox.
(C) Immunoblot of representative Ctr1flox/flox (flox)
and Ctr1hrt/hrt (hrt) mouse tissues for ATP7A and
Actin (as loading control). H, heart; M, muscle; B,
brain; L, liver; K, kidney.
(D) Semiquantitative RT-PCR for ATP7A and
ATP7B. GAPDH was assayed as an input control.
(E) Immunohistochemistry of Ctr1flox/flox and
Ctr1hrt/hrt mouse liver with anti-ATP7A antibody.
Enriched ATP7A expression toward the sinusoidal
space is indicated with arrowheads. The central
vein (CV) is indicated. Scale bar, 50 mm.
(F) Immunoblot analysis of total Triton X-100
solubilized liver extracts from two representative
Ctr1flox/flox andCtr1hrt/hrtmouse tissues for ATP7A,
ATP7B, and ceruloplasmin (Cp) and tubulin as
a loading control.
(G) Immunoblot analysis of ATP7A and CCS in
the IECs of two representative Ctr1flox/flox and
Ctr1hrt/hrt mice. Actin levels were assayed as
a loading control. For (F) and (G), 1 and 2 indicate
samples from two independent mice of each
genotype.
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mature and reach an adequate Cu status.
Data presented here demonstrate that a genetically pro-
grammed cardiac Cu deficiency results in dramatically elevated
intestinal epithelial and hepatic ATP7A expression and a parallel
decrease in liver Cu stores and increase in circulating Cu. These
observations are consistent with ATP7A playing an unantici-
pated role in the mobilization of hepatic Cu stores. To test
whether ATP7A could play such a role under more physiologi-
cally relevant conditions, we examined ATP7A protein levels
from wild-type pups reared on a Cu-deficient (D) diet or a
Cu-adequate (A) diet for 5 weeks beginning post natal day 2.
As shown in Figure 6D, ATP7A levels in IECs from mice
reared on a Cu-deficient diet are dramatically elevated as
compared to mice reared on a normal diet. The steady-state
CCS levels were elevated andCOX IV levels decreased in tissues358 Cell Metabolism 11, 353–363, May 5, 2010 ª2010 Elsevier Inc.from mice raised on a Cu-deficient diet,
with the changes of COX IV and CCS
particularly evident in the heart and
consistent with higher Cu demands for
cardiac function. Limited Cu availability
from diet as well as the efflux of Cu via
the action of ATP7A in IECs may cause
a Cu deficiency in the cells, resulting in
a higher level of CCS. Interestingly, the
dietary Cu-deficiency regimen used here
did not result in increased hepaticATP7A. While the reason that ATP7A in the liver was not
increased in these mice is not clear, it is possible that the stored
Cu in the liver has already been depleted after this period of
growth on a Cu-deficient diet. Taken together, these data
strongly suggest that ATP7A plays an important role in the mobi-
lization of hepatic Cu stores and, further, that elevating intestinal
Cu absorption may be a primary mode of enhancing Cu supplies
to peripheral tissues after a stage when liver Cu stores have been
diminished.
ATP7A Activation by a Circulating Signal from Ctr1hrt/hrt
Mice
To further test if the Ctr1hrt/hrt mice possess a circulating signal
that induces ATP7A expression, human primary umbilical vein
endothelial cells (HUVECs) were treated with serum from control
or Ctr1hrt/hrtmice. The data shown in Figure 7A demonstrate that
Figure 6. ATP7A Expression Correlates
with Hepatic Cu Mobilization
(A) Immunoblot analysis of ATP7A, Ceruloplasmin
(Cp), COX IV, and SOD1 in the liver of wild-type
C57BL mice during maturation. P5, postnatal
day 5; P10, postnatal day 10; 4W, 4-week-old
mice; 6M, 6-month-old mice.
(B) Liver Cu levels from wild-type mice. P5, post-
natal day 5; P10, postnatal day 10; 4W, 4-week-
old mice; 6M, 6-month-old mice. Error bars, SD;
n = 5 for each group.
(C) Comparison of hepatic ATP7A levels between
a representative 10-day-old Ctr1hrt/hrt (hrt) mouse
and wild-type mice at P5, postnatal day 5; P10,
postnatal day 10; 4W, 4-week-old mice; 6M,
6-month-old mice.
(D) ATP7A expression levels (short exposure as
well as longer exposure shown) in the intestinal
epithelial cells (IEC), liver (LIV), and heart (HRT) in
response to a Cu-limited diet in wild-type C57BL
mice. CCS and COX IV were assayed as cellular
Cu level indicators, and SOD1 is shown as a
loading control. ‘‘A’’ indicates a copper-adequate
diet, and ‘‘D’’ indicates a copper-deficient diet.
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increased ATP7A expression beyond that of serum from control
mice. Increased CCS levels in the cells treated with serum from
Ctr1hrt/hrt mice suggest decreased intracellular Cu levels due to
the action of ATP7A pumping Cu from these cells. Furthermore,
treatment of a human intestinal epithelial-like cell line (Caco-2)
with serum from Ctr1hrt/hrt mice also increased ATP7A expres-
sion compared to serum from control mice (Figure 7B). These
data suggest that Ctr1hrt/hrt mice possess a positively acting
diffusible signal that is able to stimulate expression of the
ATP7A Cu efflux pump.
DISCUSSION
The experimental results presented here demonstrate that
cardiac-specific loss of the Ctr1 Cu transporter results in a
reduction in cardiac Cu levels and the generation of morpholog-
ical, histological, molecular, and physiological hallmarks of
cardiac hypertrophy. These observations underscore the strong
cardiac-intrinsic requirement for Cu acquisition, driven by the
evolutionary conserved Ctr1 Cu transporter, rather than a more
global peripheral Cu deficiency that impacts on cardiac function.
While cardiac tissue has a high demand for Cu to support oxida-
tive phosphorylation, oxidative stress protection, and other
functions, it is currently not well understood which cardiac
functions are exquisitely sensitive to Cu deficiency to manifest
in a cardiomyopathy, both in fruit flies and in mice. Mutations
in the human SCO2 gene, encoding a protein involved in
the delivery of Cu to mitochondrial cytochrome oxidase, have
been shown to cause fatal infantile cardiomyopathy (Jaksch
et al., 2000), and ATP7A plays an important role in the regulation
of extracellular superoxide dismutase (EC-SOD) activity and
vascular nitric oxide signaling (Qin et al., 2008), further under-
scoring the severe cardiac health consequences of both dietary
and genetically imposed defects in Cu acquisition or cellular Cu
delivery.COne mediator of cardiac hypertrophy, the NFAT phosphatase
calcineurin, might have a link to Cu metabolism via functional
interactions with Cu, Zn SOD (Wang et al., 1996). However, given
that mice lacking Cu, Zn SOD do not develop apparent cardiac
hypertrophy (Elchuri et al., 2005; Yoshida et al., 2000), it is
unlikely that Cu, Zn SOD is the critical Cu deficiency-sensitive
target that leads to hypertrophy. A recent study in mice sug-
gested Cu supplementation partially prevents hypertrophic
cardiac dysfunction through the copper chaperone for Cu, Zn
SOD (CCS)-mediated HIF-1a activation and VEGF expression
(Jiang et al., 2007). However, no causal relationship between
CCS and cardiac hypertrophy has been established, and neither
CCS nor SOD1 knockout mice have been reported to suffer from
cardiac hypertrophy. The cardiac-specific Ctr1 knockout mice
will be a valuable animal model for deciphering the mechanisms
by which Cu deficiency induces cardiac hypertrophy.
The components involved in the acquisition, distribution, and
utilization of Cu at the cellular level, and their modes of action,
have been extensively investigated. However, the precise
mechanisms by which Cu is transferred from IECs to the portal
circulation and is then mobilized from hepatic stores to the
periphery are poorly understood. Furthermore, while it is well
established that the intestinal enterocyte is a key regulatory point
for Cu absorption into the body, how these cells respond to
changes in Cu status in the periphery remains poorly under-
stood. Studies on cardiac-specific Ctr1 knockout mice pre-
sented here suggest that ATP7A may be responsible for Cu
mobilization from the liver when peripheral tissues become Cu
deficient. This possibility was unexpected, since ATP7A is
thought to function primarily in extrahepatic tissues and its
expression levels in the liver of mature mice are very low (Paynter
et al., 1994). However, given the localization of ATP7A in
endothelial cells lining hepatic sinusoidal spaces, and the
dramatic elevation of hepatic ATP7A mRNA and protein levels
in Ctr1hrt/hrt mice, these observations are consistent with a role
for ATP7A in the mobilization of hepatic Cu stores when one orell Metabolism 11, 353–363, May 5, 2010 ª2010 Elsevier Inc. 359
Figure 7. In Vitro Activation of ATP7A Protein in Serum-Treated
Human Cells
(A) Immunoblot analysis of ATP7A and CCS levels in HUVEC cells treated with
serum from control Ctr1flox/flox and Ctr1hrt/hrt mice. Actin levels were assayed
as a loading control.
(B) Immunoblot analysis of ATP7A and CCS levels in Caco-2 cells treated
with serum from control Ctr1flox/flox and Ctr1hrt/hrt mice. Tubulin levels were
assayed as a loading control. The source of the serum is indicated by the
mouse genotype.
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the high-level expression of ATP7A in early postnatal mice,
when liver Cu stores are high and gradually diminish over time
to maturity, the ATP7A protein expression data are also consis-
tent with a role for ATP7A in hepatic Cumobilization during post-
natal development.
An unexpected observation from the analysis ofCtr1hrt/hrtmice
is the diminution of liver Cu stores in parallel with increases in
serum Cu. These changes, in concert with the dramatically
increased levels of ATP7A in both IECs and the liver, suggest
that the Cu-deficient cardiac tissue from Ctr1hrt/hrt mice may
be able to communicate with the intestine and the liver to
enhance the expression of the ATP7A Cu exporter from the sites
of dietary uptake and storage. Since Ctr1hrt/hrt mice do not have
elevated serum Zn or Fe levels compared to wild-type litter-
mates, this would be consistent with a signal from the heart
that reports on the cardiac Cu status specifically, rather than
metals in general. Interestingly, analysis of wild-type mice reared
on a Cu-limited diet revealed that ATP7A expression was
dramatically elevated only in IECs. While this may reflect differ-
ences in peripheral Cu deficiency or timing between theCtr1hrt/hrt
mice and dietary Cu deficiency of wild-type mice, it may also
suggest that intestinal Cu uptake is the major target tissue for
regulation after hepatic Cu stores are strongly depleted in adult
mice.
These results suggest the existence a diffusible systemic
Cu-regulatory system that is reminiscent of the hepcidin-medi-
ated control of systemic iron homeostasis. In response to Fe
overload, the liver produces elevated levels of mRNA encoding
hepcidin, a polypeptide that interacts with the ferroportin Fe
exporter on the basolateral membrane of IECs to shut down Fe
efflux into the circulation (De Domenico et al., 2008; Muck-
enthaler, 2008; Nemeth et al., 2004).
Our study suggests that the Cu-deficient heart alters the func-
tion or expression of a molecule that, directly or indirectly, posi-
tively influences ATP7A expression in the liver and intestine.360 Cell Metabolism 11, 353–363, May 5, 2010 ª2010 Elsevier Inc.Recent studies in tissue-culture models suggest that ATP7A
and ATP7B are regulated by lactational hormones, inflammatory
cytokines, lipopolysaccharide, and growth factors (Ackland
et al., 1999; Hardman et al., 2007; Michalczyk et al., 2008; White
et al., 2009), demonstrating the potential for small molecule
regulation of systemic Cu metabolism. More extensive studies
will be needed to comprehensively test this possibility and to
understand the precise signals and regulatory events that
lead to increases in ATP7A expression as a mechanism to
enhance Cu acquisition and mobilization during fluctuations in
Cu availability.
EXPERIMENTAL PROCEDURES
Drosophila Stocks and Breeding
W1118 stocks were obtained from the Bloomington Drosophila stock center.
The TinCGal4 transgenic was a generous gift from Manfred Frasch (Lo and
Frasch, 2001). The UAS-Ctr1ARNAi construct was generated as described
(Lee and Carthew, 2003); establishment of transgenic lines carrying the
construct was carried out according to standard methods (Cooley et al.,
1990). All crosses were performed and control lines maintained at 29C in
a humidity-controlled incubator until OCT measurements were performed.
OCT Measurements
Fourteen wild-type (W1118) female flies, 12 TinCGal4 females, and 24
TinCGal4/UAS-Ctr1ARNAi females, all of which were at least 1 week old,
were used in optical coherence tomography (OCT) analysis. For the dorsal
vessel-specific knockdown of Ctr1A, two independent insertion lines of the
UAS-Ctr1ARNAi cassette, one on the second chromosome and one on the third
chromosome, were crossed to TinCGal4 flies and subjected to OCT analysis.
Data using the third chromosome insert are reported here, though similar
results were obtainedwith the transgene inserted on the second chromosome.
OCT measurements were carried out as described (Wolf et al., 2006).
Generation of Cardiac-Specific Ctr1-Conditional Knockout Mice
Ctr1-floxed (Ctr1flox/flox) mice have been described (Nose et al., 2006a).
Ctr1flox/flox mice were crossbred with a-MHC-Cre mice (Center for Cardiovas-
cular Development, Baylor College of Medicine) to generate MHC-Cre;
Ctr1flox/+ mice. The MHC-Cre; Ctr1flox/+ mice were crossbred with Ctr1flox/flox
mice, and Ctrhrt/hrt mice were obtained. The genotypes of offspring from the
cross as well as tissue excision of Ctr1 were determined by standard PCR
method as described (Nose et al., 2006a). Age-matched siblings were used
for all experiments. To generate inducible cardiac-specific Ctr1 knockout
mice, Ctr1flox/flox mice were crossbred with a-MHC-Cre-ER mice (Jackson
Laboratory) to generate MHC-Cre-ER; Ctr1flox/+ mice. The MHC-Cre-ER;
Ctr1flox/+ mice were crossbred with Ctr1flox/flox mice, and MHC-Cre-ER;
Ctr1flox/flox mice were obtained. 4-hyroxytamoxifen (4-OHT) was prepared as
described previously (Indra et al., 1999). Two- or seven-month-old Ctr1flox/flox
mice and MHC-Cre-ER; Ctr1flox/flox mice were injected intraperitoneally with
100 ml of a 4-OHT stock solution (10 mg/ml) for 5 consecutive days and
sacrificed either after the last injection or 3–5 days after the final injection. All
animal protocols were approved by the Duke University Institutional Animal
Care & Use Committee.
Tissue Preparation and Analysis
Tissues were dissected after perfusion with phosphate-buffered saline
(pH7.4; PBS), frozen in liquid nitrogen, and storedat80Cuntil use.Dissected
tissues were homogenized in ice-cold cell lysis buffer (PBS [pH 7.4], 1% Triton
X-100, 0.1% sodium dodecyl sulfate [SDS], 1 mM EDTA) containing protease
inhibitor cocktail (Roche). Homogenates were incubated on ice for 30 min
and centrifuged at 16,000 3 g for 10 min at 4C. The supernatants were used
for immunoblotting. Equal amounts of protein (100 mg/lane) were fractionated
on a 4%–20% gradient gel (Bio-Rad). Anit-Ctr1 antibody (Nose et al.,
2006a), anti-CCS antibody (Santa Cruz), and anti-SOD1 (BD Biosciences)
were used at a 1:2000 dilution. Anti-tubulin (Sigma) antibody and anti-COX IV
antibody (Invitrogen) were used at 1:5000 dilution and 1:4000 dilution,
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A Systemic Cu Homeostasis Regulatory Mechanismrespectively. Anti-SERCA2 antibody (Santa Cruz) was used at a 1:1000
dilution. Anti-PLB antibody (Santa Cruz) and anti-phospho-phospholamban
(Upstate) were used according to the provider’s instructions. Phosphatase
inhibitor cocktail (Thermo Scientific) was included in the lysis buffer, and gels
were run in duplicate for P-PLB westerns. Copper concentrations were
measured from nitric acid-digested tissues by inductively coupled plasma
mass spectrometry (ICP-MS) as described (Nose et al., 2006a). The values
were normalized to tissue wet weight. For cytochrome oxidase assays, tissues
were homogenized in 5–10 volumes of 50 mM phosphate buffer (pH 6.8) con-
taining 0.5%Tween 80 and incubated on ice for 10min. Protein concentrations
were measured by the Bio-Rad Protein DC Assay kit (Bio-Rad), and cyto-
chrome oxidase activity was measured using a Cytochrome C Oxidase Assay
Kit (Sigma).
Histology
For hematoxylin and eosin (H&E) staining and immunohistochemistry, mice
were euthanized and perfused with PBS (pH 7.4). Tissues were then dissected
and fixed in 4% paraformaldehyde at 4C overnight with gentle agitation. After
fixation, tissues were dehydrated in 70% ethanol and embedded in paraffin.
Six micrometer thick sections were either stained with H&E or used for
immunohistochemistry. After deparaffinization and hydrolysis in PBS, immu-
nohistochemical staining was performed with the Super Sensitive Link-
Labeled IHC Detection System (BioGenex, San Ramon, CA). Ten percent
normal goat serum (Sigma, Saint Louis, MO) in PBS was used for blocking.
Anti-ATP7A (1:200 dilution in 1% normal goat serum-PBS) was used as
primary antibody for 1 hr at room temperature. After developing using DAB
substrate, sections were counterstained with hematoxylin. For electron
microscopy, heart tissue was immersed in a fixative containing 2% glutaralde-
hyde immediately after dissection and incubated at 4C overnight. Sectioning,
staining, microscopy, and image capture were carried out via the histology
service core of the Department of Pathology, Duke University Medical Center
(Durham, NC).
RNA Analysis
Total RNAwas isolated frommouse heart using the RNeasy Kit (QIAGEN). RNA
blotting was performed by standard methods using 20 mg total RNA from
cardiac tissue. Membranes were probed with 32P-labeled DNA derived from
ANF, BNP, and SA cDNA sequences. For semiquantitative RT-PCR, cDNA
was synthesized with SuperScript III Kit (Invitrogen), and the target genes
were amplified using primers listed in Table S1, electrophoresed on a 2%
agarose gel, and visualized by ethidium bromide staining.
Echocardiography and Electrocardiography
Cardiac function and left ventricle dimensions were evaluated by echocardiog-
raphy in conscious mice as previously described (Esposito et al., 2000).
Electrocardiography was performed under light anesthetizia (isofluorane
inhalation).
Dietary Experiments
Dams fromwild-type mice were fed Cu-adequate or Cu-deficient diets (Teklad
Laboratories, Madison, WI) beginning on the second day postdelivery with
their pups. The Cu deficient diet has been previously described (Kuo et al.,
2006). The mice were weaned at 3 weeks of age. After weaning, mice were
maintained on the same normal or Cu-deficient diet for 2 weeks.
SUPPLEMENTAL INFORMATION
Supplemental Information includes three figures and one table and can be
found with this article at doi:10.1016/j.cmet.2010.04.003.
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